Skip to main content

Featured Content

As part of its Project DAWN initiative, MetroHealth in Cleveland has outfitted an RV it can use to distribute naloxone, serve as a syringe exchange and provide other resources to at-risk individuals in Northeast Ohio.
Toronto-based Awakn Life Sciences and contract research organization PRA Health Sciences have announced plans to study MDMA-assisted psychotherapy as a treatment for patients with alcohol use disorder.
HHS is publishing new guidelines that will expand access to medication-assisted treatment for opioid use disorder by exempting physicians from certain certification requirements necessary for prescribing buprenorphine.
Results of a clinical trial published by NIH on Wednesday showed that a combination of two medications—injectable naltrexone and oral bupropion—were safe and effective in the treatment of adults with moderate or severe methamphetamine use disorder.
Results of a NIDA-supported pilot study released on Monday showed that collaboration between physicians and pharmacists could lead to improved medication adherence among patients being treated for opioid use disorder.

Meetings & Publications

Back to Top